Do you have a question about BioAFM? This article will tell you everything you need to know.
Biogen CEO seeks ‘awful lot more collaborations’ to beef up R&D as it launches postpartum depression, Alzheimer’s and ALS drugs
Biogen CEO Chris Viehbacher said the famed Boston biotech is ready to do “an awful lot more collaborations” as it seeks to fill out its